annual CFO:
$10.32M+$81.27M(+114.55%)Summary
- As of today (September 16, 2025), MIRM annual cash flow from operations is $10.32 million, with the most recent change of +$81.27 million (+114.55%) on December 31, 2024.
- During the last 3 years, MIRM annual CFO has risen by +$143.08 million (+107.78%).
- MIRM annual CFO is now at all-time high.
Performance
MIRM Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$12.04M+$14.00M(+713.97%)Summary
- As of today (September 16, 2025), MIRM quarterly cash flow from operations is $12.04 million, with the most recent change of +$14.00 million (+713.97%) on June 30, 2025.
- Over the past year, MIRM quarterly CFO has increased by +$15.84 million (+416.59%).
- MIRM quarterly CFO is now -20.85% below its all-time high of $15.21 million, reached on March 31, 2024.
Performance
MIRM quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$8.99M+$15.84M(+231.35%)Summary
- As of today (September 16, 2025), MIRM TTM cash flow from operations is $8.99 million, with the most recent change of +$15.84 million (+231.35%) on June 30, 2025.
- Over the past year, MIRM TTM CFO has increased by +$32.42 million (+138.39%).
- MIRM TTM CFO is now -12.88% below its all-time high of $10.32 million, reached on December 31, 2024.
Performance
MIRM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MIRM Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +114.5% | +416.6% | +138.4% |
3 y3 years | +107.8% | +159.7% | +107.1% |
5 y5 years | +126.2% | +170.8% | +114.0% |
MIRM Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +107.8% | -20.9% | +135.1% | -12.9% | +107.1% |
5 y | 5-year | at high | +107.8% | -20.9% | +129.9% | -12.9% | +106.1% |
alltime | all time | at high | +107.8% | -20.9% | +129.9% | -12.9% | +106.1% |
MIRM Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $12.04M(-714.0%) | $8.99M(-231.4%) |
Mar 2025 | - | -$1.96M(-61.3%) | -$6.85M(-166.3%) |
Dec 2024 | $10.32M(-114.6%) | -$5.07M(-227.2%) | $10.32M(-942.9%) |
Sep 2024 | - | $3.98M(-204.8%) | -$1.23M(-94.8%) |
Jun 2024 | - | -$3.80M(-125.0%) | -$23.43M(+6.7%) |
Mar 2024 | - | $15.21M(-191.5%) | -$21.96M(-69.0%) |
Dec 2023 | -$70.94M(-40.9%) | -$16.62M(-8.8%) | -$70.94M(-19.9%) |
Sep 2023 | - | -$18.22M(+681.7%) | -$88.60M(-8.1%) |
Jun 2023 | - | -$2.33M(-93.1%) | -$96.40M(-15.6%) |
Mar 2023 | - | -$33.77M(-1.4%) | -$114.24M(-4.9%) |
Dec 2022 | -$120.14M | -$34.27M(+31.7%) | -$120.14M(+0.9%) |
Sep 2022 | - | -$26.02M(+29.0%) | -$119.01M(-6.4%) |
Jun 2022 | - | -$20.17M(-49.1%) | -$127.19M(-13.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$39.67M(+19.7%) | -$147.22M(+10.9%) |
Dec 2021 | -$132.76M(+49.0%) | -$33.15M(-3.1%) | -$132.76M(-2.3%) |
Sep 2021 | - | -$34.20M(-14.9%) | -$135.89M(+14.1%) |
Jun 2021 | - | -$40.20M(+59.5%) | -$119.14M(+24.2%) |
Mar 2021 | - | -$25.21M(-30.5%) | -$95.93M(+7.7%) |
Dec 2020 | -$89.08M(+126.3%) | -$36.28M(+107.9%) | -$89.08M(+34.0%) |
Sep 2020 | - | -$17.45M(+2.7%) | -$66.49M(+3.5%) |
Jun 2020 | - | -$16.99M(-7.4%) | -$64.26M(+16.2%) |
Mar 2020 | - | -$18.35M(+34.0%) | -$55.29M(+40.5%) |
Dec 2019 | -$39.36M(>+9900.0%) | -$13.70M(-10.0%) | -$39.36M(+53.4%) |
Sep 2019 | - | -$15.22M(+89.9%) | -$25.66M(+145.8%) |
Jun 2019 | - | -$8.02M(+230.5%) | -$10.44M(+330.5%) |
Mar 2019 | - | -$2.43M | -$2.43M |
Dec 2018 | -$373.00K | - | - |
FAQ
- What is Mirum Pharmaceuticals, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. annual CFO year-on-year change?
- What is Mirum Pharmaceuticals, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. quarterly CFO year-on-year change?
- What is Mirum Pharmaceuticals, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. TTM CFO year-on-year change?
What is Mirum Pharmaceuticals, Inc. annual cash flow from operations?
The current annual CFO of MIRM is $10.32M
What is the all time high annual CFO for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high annual cash flow from operations is $10.32M
What is Mirum Pharmaceuticals, Inc. annual CFO year-on-year change?
Over the past year, MIRM annual cash flow from operations has changed by +$81.27M (+114.55%)
What is Mirum Pharmaceuticals, Inc. quarterly cash flow from operations?
The current quarterly CFO of MIRM is $12.04M
What is the all time high quarterly CFO for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high quarterly cash flow from operations is $15.21M
What is Mirum Pharmaceuticals, Inc. quarterly CFO year-on-year change?
Over the past year, MIRM quarterly cash flow from operations has changed by +$15.84M (+416.59%)
What is Mirum Pharmaceuticals, Inc. TTM cash flow from operations?
The current TTM CFO of MIRM is $8.99M
What is the all time high TTM CFO for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high TTM cash flow from operations is $10.32M
What is Mirum Pharmaceuticals, Inc. TTM CFO year-on-year change?
Over the past year, MIRM TTM cash flow from operations has changed by +$32.42M (+138.39%)